Futura Medical plc (FAMDF)
- Previous Close
0.3800 - Open
0.5000 - Bid --
- Ask --
- Day's Range
0.4200 - 0.5000 - 52 Week Range
0.1500 - 2.7000 - Volume
13,000 - Avg. Volume
15,473 - Market Cap (intraday)
132.951M - Beta (5Y Monthly) 1.24
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
www.futuramedical.comRecent News: FAMDF
Performance Overview: FAMDF
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FAMDF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FAMDF
Valuation Measures
Market Cap
133.66M
Enterprise Value
124.01M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
32.06
Price/Book (mrq)
18.56
Enterprise Value/Revenue
39.99
Enterprise Value/EBITDA
-18.15
Financial Highlights
Profitability and Income Statement
Profit Margin
-210.03%
Return on Assets (ttm)
-47.60%
Return on Equity (ttm)
-127.75%
Revenue (ttm)
3.1M
Net Income Avi to Common (ttm)
-6.51M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
7.71M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
1.25M
Company Insights: FAMDF
FAMDF does not have Company Insights